← Back to Clinical Trials
Recruiting NCT07165964

NCT07165964 Nursing Interventions to Enhance Positive Mental Health and Self Care in Women During the Climacteric

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07165964
Status Recruiting
Phase
Sponsor University of Barcelona
Condition Climacteric Symptoms
Study Type INTERVENTIONAL
Enrollment 250 participants
Start Date 2025-07-31
Primary Completion 2026-07-01

Eligibility & Interventions

Sex Female only
Min Age 42 Years
Max Age 58 Years
Study Type INTERVENTIONAL
Interventions
Personal interventions in Climateric

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 250 participants in total. It began in 2025-07-31 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will test whether a nursing program using podcasts and videos can help women feel better and take better care of themselves during the climacteric (the stage leading up to and following menopause). Women between 42 and 58 years old who attend public sexual and reproductive health clinics in the Metropolitan South Health Region of Barcelona (Sant Boi, Sant Feliu, and Cornellà) will be invited to participate. Participants will be randomly assigned to one of two groups: Intervention Group: will receive access to podcasts and videos offering practical advice and strategies to improve emotional well-being and self-care. Control Group: will receive standard care. All participants will complete questionnaires before and after the program to assess symptoms, mental health, and satisfaction with self-care. Statistical methods will be used to compare the results between both groups and determine whether the program produces a significant difference. The aim of the study is to demonstrate that this digital nursing intervention is effective and could be implemented more broadly in healthcare settings.

Eligibility Criteria

Inclusion Criteria: * Women aged 42-58 years attending the participating ASSIR centers. * Clinically identified symptoms of climacteric during routine consultation. Exclusion Criteria: * Cognitive or learning impairments preventing comprehension of study procedures. * Physical, emotional, or intellectual limitations hindering completion of study instruments or participation in the intervention. * Current treatment for hormone dependent cancer. * Use of an intrauterine device or ongoing hormonal contraceptives. * Other medical causes of secondary menopause.

Contact & Investigator

Central Contact

Monste Puig-Llobet, Monsterrat, Professor

✉ monpuigllob@ub.edu

📞 934 02 42 56

Principal Investigator

Monsterrat Puig-Llobet

PRINCIPAL INVESTIGATOR

Universitat de Barelona

Frequently Asked Questions

Who can join the NCT07165964 clinical trial?

This trial is open to female participants only, aged 42 Years or older, up to 58 Years, studying Climacteric Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07165964 currently recruiting?

Yes, NCT07165964 is actively recruiting participants. Contact the research team at monpuigllob@ub.edu for enrollment information.

Where is the NCT07165964 trial being conducted?

This trial is being conducted at L'Hospitalet de Llobregat, Spain.

Who is sponsoring the NCT07165964 clinical trial?

NCT07165964 is sponsored by University of Barcelona. The principal investigator is Monsterrat Puig-Llobet at Universitat de Barelona. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology